1348 Translational biomarkers of response to triplet maintenance in BRCA wildtype recurrent ovarian cancer: OPEB-01/APGOT-OV4
Kim, Yoo-Na, Park, Boram, Kim, Jae Weon, Kim, Byoung Gie, Kim, Sang Wun, Kim, Hee Seung, Choi, Chel Hun, Lim, Myong Cheol, Ngoi, Natalie Yl, Tan, David Sp, Lee, Jung-Yun
Published in International journal of gynecological cancer (10.03.2024)
Published in International journal of gynecological cancer (10.03.2024)
Get full text
Journal Article
The redox-senescence axis and its therapeutic targeting
Ngoi, Natalie YL, Liew, Angeline QX, Chong, Stephen J.F., Davids, Matthew S., Clement, Marie-Veronique, Pervaiz, Shazib
Published in Redox biology (01.09.2021)
Published in Redox biology (01.09.2021)
Get full text
Journal Article
Exploiting replicative stress in gynecological cancers as a therapeutic strategy
Ngoi, Natalie YL, Sundararajan, Vignesh, Tan, David SP
Published in International journal of gynecological cancer (01.08.2020)
Published in International journal of gynecological cancer (01.08.2020)
Get full text
Journal Article
A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma
Heong, Valerie, Tan, Tuan Z, Miwa, Maiko, Ye, Jieru, Lim, Diana, Herrington, C Simon, Iida, Yasushi, Yano, Mitsutake, Yasuda, Masanori, Ngoi, Natalie YL, Wong, SB Justin, Okamoto, Aikou, Gourley, Charlie, Hasegawa, Kosei, Tan, David SP, Huang, Ruby YJ
Published in The Journal of pathology (01.11.2021)
Published in The Journal of pathology (01.11.2021)
Get full text
Journal Article
Combined modality management of advanced cervical cancer including novel sensitizers
Tseng, Michelle, Ngoi, Natalie YL, Tan, David SP, Tong, Pearl SY
Published in International journal of gynecological cancer (01.03.2022)
Published in International journal of gynecological cancer (01.03.2022)
Get full text
Journal Article
A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
Lee, Yong Jae, Lim, Myong Cheol, Kim, Byoung Gie, Ngoi, Natalie Yl, Choi, Chel Hun, Park, Sang Yoon, Tan, David Sp, Go, Yunjung, Lee, Jung Yun
Published in Journal of gynecologic oncology (01.03.2021)
Published in Journal of gynecologic oncology (01.03.2021)
Get full text
Journal Article
A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician’s choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)
Ngoi, Natalie YL, Heong, Valerie, Ow, Samuel, Chay, Wen Yee, Kim, Hee Seung, Choi, Chel Hun, Goss, Geraldine, Goh, Jeffrey C, Tai, Bee Choo, Lim, Diana GZ, Kaliaperumal, Nivashini, Au, Veonice B, Connolly, John E, Kim, Jae-Weon, Friedlander, Michael, Kim, Kidong, Tan, David SP
Published in International journal of gynecological cancer (01.08.2020)
Published in International journal of gynecological cancer (01.08.2020)
Get full text
Journal Article
Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience
Wijaya, Silvana Talisa, Ngoi, Natalie Yl, Loh, Jerold Wz, Tan, Tuan Zea, Lim, Diana, Khan, Irfan Sagir, Thian, Yee Liang, Lai, Alexa, Ang, Bertrand Wl, Tong, Pearl, Ng, Joseph, Low, Jeffrey Jh, Ilancheran, Arunachalam, Lim, Siew Eng, Lim, Yi Wan, Tan, David Sp
Published in Journal of gynecologic oncology (01.09.2024)
Published in Journal of gynecologic oncology (01.09.2024)
Get full text
Journal Article
PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report
Sachdeva, Manavi, Ngoi, Natalie Y L, Lim, Diana, Poon, Michelle L M, Thian, Yee Liang, Lim, Yi Wan, Lim, Siew Eng, Tong, Pearl, Lum, Jeffrey H Y, Ng, Joseph, Ilancheran, Arunachalam, Domingo, Efren J, Low, Jeffrey J H, Tan, David S P
Published in OncoTargets and therapy (2021)
Published in OncoTargets and therapy (2021)
Get full text
Journal Article
Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
Kim, Yoo-Na, Park, Boram, Kim, Jae Weon, Kim, Byoung Gie, Kim, Sang Wun, Kim, Hee Seung, Choi, Chel Hun, Lim, Myong Cheol, YL Ngoi, Natalie, SP Tan, David, Lee, Jung-Yun
Published in Nature communications (06.09.2023)
Published in Nature communications (06.09.2023)
Get full text
Journal Article
Uterine serous carcinoma
Bogani, Giorgio, Ray-Coquard, Isabelle, Concin, Nicole, Ngoi, Natalie Y.L., Morice, Philippe, Enomoto, Takayuki, Takehara, Kazuhiro, Denys, Hannelore, Nout, Remi A., Lorusso, Domenica, Vaughan, Michelle M., Bini, Marta, Takano, Masashi, Provencher, Diane, Indini, Alice, Sagae, Satoru, Wimberger, Pauline, Póka, Robert, Segev, Yakir, Kim, Se Ik, Candido dos Reis, Francisco J., Lopez, Salvatore, Mariani, Andrea, Leitao, Mario M., Raspagliesi, Francesco, Panici, Pieluigi Benedetti, Di Donato, Violante, Muzii, Ludovico, Colombo, Nicoletta, Scambia, Giovanni, Pignata, Sandro, Monk, Bradley J.
Published in Gynecologic oncology (01.07.2021)
Published in Gynecologic oncology (01.07.2021)
Get full text
Journal Article
Triplet maintenance (olaparib, pembrolizumab, and bevacizumab) in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer: A multi-center, single-arm phase II study (OPEB-01)
Kim, Yoo Na, Park, Boram, Joung, Je-Gun, Kim, Jae-Weon, Kim, Byoung-Gie, Kim, Sang Wun, Kim, Hee Seung, Choi, Chel Hun, Lim, Myong Cheol, Ngoi, Natalie Yl, Tan, David Shao Peng, Lee, Jung-Yun
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer
Ngoi, Natalie Yl, Syn, Nicholas Lx, Goh, Robby M, Goh, Boon Cher, Huang, Ruby Yun-Ju, Soon, Yu Yang, James, Elizabeth, Cook, Adrian, Clamp, Andrew, Tan, David Sp
Published in Cochrane database of systematic reviews (21.02.2022)
Published in Cochrane database of systematic reviews (21.02.2022)
Get more information
Journal Article
Therapeutic applications of germline testing for cancer predisposition genes in Asia in the real world
Cheo, Seng Wee, Ong, Pei-Yi, Ow, Samuel Guan Wei, Chan, Gloria Hui Jia, Tan, David Shao Peng, Lim, Yi Wan, Kong, Hwai L., Wong, Andrea, Lim, Siew Eng, Walsh, Robert John, Wong, Alvin S.C., Low, Jeffrey, Ngoi, Natalie Yl, Lim, Joline Si Jing, Lee, Soo-Chin
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Quality of life (QoL) in patients with recurrent ovarian clear cell carcinoma (rOCCC) receiving durvalumab (D) versus physician’s choice chemotherapy (PCC) in the randomized phase II MOCCA/APGOT-OV2/GCGS-OV3 trial
Ngoi, Natalie YL, Sun, Haoyang, Choi, Chel Hun, Heong, Valerie, Ow, Samuel Guan Wei, Chay, Wen Yee, Kim, Hee Seung, Goss, Geraldine, Goh, Jeffrey C., Lin, Meiqi, Lim, Diana, Kim, Jae-Weon, Friedlander, Michael, Tai, Bee Choo, Kim, Kidong, Tan, David Shao Peng
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Immune checkpoint inhibition for non-small cell lung cancer in patients with pulmonary tuberculosis or Hepatitis B: Experience from a single Asian centre
Chan, Gloria HJ, Gwee, Yong Xiang, Low, Jia Li, Huang, Yiqing, Chan, Zhi Yao, Choo, Joan RE, Ngoi, Natalie YL, LE Ang, Yvonne, Muthu, Vaishnavi, Chong, Wan Qin, Wong, Alvin, Soo, Ross A.
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2020)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2020)
Get full text
Journal Article
PD-LI Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report
Sachdeva, Manavi, Ngoi, Natalie YL, Lim, Diana, Poon, Michelle LM, Thian, Yee Liang, Lim, Yi Wan, Lim, Siew Eng, Tong, Pearl, Lum, Jeffrey H.Y, Ng, Joseph, Ilancheran, Arunachalam, Domingo, Efren J, Low, Jeffrey J.H, Tan, David S.P
Published in OncoTargets and therapy (30.06.2021)
Published in OncoTargets and therapy (30.06.2021)
Get full text
Journal Article